Mechanisms of regulation of the PI#K/AKT pathway downstream of NOTCH1 in T-ALL.
|
Columbia University / Teresa Palomero, PhD |
Young Investigator Grants |
2007 |
New York |
Function of the PR Domain of the MDSI-EVI1 in MLL Fusion Protein Leukemogenesis |
University of Rochester / Archibald Perkins, MD, PhD |
Springboard Grants |
2013 |
New York |
A leukemia organoid platform for dissection and targeting of tumor-niche interactions |
Columbia Institute for Cancer Genetics / Adolfo Ferrando, MD/PhD |
Innovation Grants |
2021 |
New York |
Functional Dissection of Oncogenic Enhancers in T-ALL |
Columbia University / Daniel Herranz, PhD |
Young Investigator Grants |
2015 |
New York |
Pre-clinical Evaluation of LSD1 Inhibitors for the Treatment of Pediatric Ewing sarcoma: Defining the Biomarkers of Sensitivity and Mechanisms of Resistance |
Research Institute at Nationwide Children's Hospital / Kathleen Pishas, PhD |
Young Investigator Grants |
2016 |
Ohio |
Generation of a novel oncolytic virus for treatment of pediatric brain tumors.
|
The Ohio State University / Balveen Kaur, PhD |
Young Investigator Grants |
2007 |
Ohio |
Untangling the Matrix in Medulloblastoma
|
St. Christopher's Hospital for Children / Duncan Stearns, MD |
Young Investigator Grants |
2008 |
Ohio |
Epigenetic manipulation of leukemia.
|
Cincinnati Children's Hospital Medical Center / H. Leighton Grimes |
Innovation Grants |
2009 |
Ohio |
Predictive Modeling of MDS Disease Progression From Inherited Bone Marrow Failure Syndrome Using Novel Branching Process and Next Generation Sequencing to Improve Patient-Specific Survival |
Cleveland Clinic Foundation / Seth Corey, MD & Marek Kimmel, PhD |
Innovation Grants |
2017 |
Ohio |
Development of MicroRNA-Nanoparticles to Treat Childhood Acute Leukemia Carrying MLL Rearrangements |
University of Cincinnati College of Medicine / Jianjun Chen, PhD |
Innovation Grants |
2013 |
Ohio |